Charles Schwab
MDLN icon

Charles Schwab’s Medline Inc MDLN Stock Holding History

Charles Schwab’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.3M Buy
1,225,577
+235,377
+24% +$9.48M 0.01% 1271
2026
Q1 		$44.1M Buy
990,200
+210,159
+27% +$9.28M 0.01% 1245
2025
Q4 		$32.8M Buy
+780,041
New +$32.9M 0.01% 1433

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Charles Schwab's MDLN Position: Q2 2026 in Review

Charles Schwab increased its Medline Inc (MDLN) stake by 24% in Q2 2026, buying an estimated $9.48M and bringing the position to 1,225,577 shares worth $48.3M. The position accounts for 0.01% of the portfolio, ranked #1271.

Charles Schwab first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. 409 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Charles Schwab held 1,225,577 shares of Medline Inc worth $48.3M as of Q2 2026.
  • Charles Schwab bought 235,377 Medline Inc shares in Q2 2026, an estimated $9.48M.
  • Medline Inc made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #1271 holding.
  • Charles Schwab first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • 409 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.